Disclaimer

You have entered the website designated for the publication of the merger document in connection with a proposed merger between COM HEM Holding AB (publ) (“COM HEM”) and Tele2 AB (publ) (“Tele2”).

In order to access the merger document in connection with the proposed merger, visitors of this website are requested to confirm, at the bottom of this page, notice of the following legal information.

ACCESSING THIS WEBSITE FROM CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW, AND PERSONS INTENDING TO ACCESS THIS WEBSITE SHOULD INFORM THEMSELVES ABOUT, AND OBSERVE, ANY SUCH RESTRICTIONS. BY ACCESSING THIS WEBSITE YOU REPRESENT THAT YOU ARE A PERSON WHO IS PERMITTED UNDER APPLICABLE LAW AND REGULATION TO RECEIVE THE MERGER DOCUMENTS

The information contains forward-looking statements. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of each of COM HEM, Tele2 or the combined company. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. Although managements of each respective company believe that their expectations reflected in any forward-looking statements are reasonable based on information currently available to them respectively, no assurance is given that such forward-looking statements will prove to have been correct. You should not place undue reliance on forward-looking statements. Such statements speak only as at the date thereof and neither COM HEM nor Tele2 undertakes any obligation to update any forward-looking statements. Past performance of COM HEM and Tele2 does not guarantee or predict future performance of the combined company. Moreover, COM HEM, Tele2, and their respective affiliates and their respective officers, employees and agents do not undertake any obligation to review, update or confirm expectations or estimates or to release any revisions to any forward-looking statements to reflect subsequent events that occur or circumstances that arise. Nothing contained within the information is or should be relied upon as a promise or representation as to the future.

By accessing the information you acknowledge that you will be solely responsible for your own assessment of COM HEM and Tele2 and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the combined company’s business and its financial performance.

You acknowledge that you have consented to accept electronic delivery of the Information. You are responsible for protecting against viruses and other destructive items. Your use of this website is at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses or other items of a destructive nature.

Additional notice to shareholders in the United States

The information provided on this website is for informational purposes only and is neither an offer to sell nor a solicitation of an offer to buy shares of COM HEM or Tele2. Tele2 has filed a registration statement on Form F-4 with the Securities and Exchange Commission (the “SEC”) in connection with the transaction. Tele2 plans to mail a US prospectus, which is part of the registration statement on Form F-4, to known US shareholders of COM HEM in connection with the transaction. The information provided on this website is not a substitute for the US prospectus, which is part of the registration statement on Form F-4. Shareholders are able to obtain free copies of US prospectus, which is part of the registration statement on Form F-4, through the website maintained by the SEC at www.sec.gov.

Free copies of the merger document may also be obtained from COM HEM, by directing a request to Mr. Marcus Lindberg, Head of Investor Relations, e-mail: marcus.lindberg@comhem.com, phone: +46 734 39 25 40. Free copies of the US prospectus may be obtained from Tele2, by directing such request to Mr. Erik Strandin Pers, Head of Investor Relations, e-mail: erik.pers@tele2.com, phone: +46 733 41 41 88.

By selecting the “I confirm” button, you warrant that you have read and understood the legal notice above.